SG Finserve Limited Receives ₹316.31 Crore Against Warrants in Q4 FY26, CARE Ratings Reports
SG Finserve Limited received ₹316.31 crore against warrants in Q4 FY26, bringing total receipts to ₹428.81 crore from its ₹450.00 crore preferential issue. Over ₹200 crore was transferred to Apollo group companies for dealer financing. CARE Ratings confirmed no deviations from offer document objectives, with ₹21.19 crore remaining to be received through warrant conversion.

*this image is generated using AI for illustrative purposes only.
SG Finserve Limited has received ₹316.31 crore against warrants during the quarter ended March 31, 2026, according to the latest monitoring agency report submitted by CARE Ratings Limited. The non-banking financial company utilized the entire amount received during the same quarter, with a significant portion directed toward dealer financing operations.
Warrant Conversion and Fund Utilization
The monitoring report reveals that SG Finserve's preferential issue of warrants worth ₹450.00 crore has progressed substantially. The company received ₹316.31 crore in Q4 FY26, adding to the initial ₹112.50 crore received at the beginning of the quarter.
| Parameter | Amount (₹ Crore) |
|---|---|
| Total Issue Size | 450.00 |
| Amount Received to Date | 428.81 |
| Received in Q4 FY26 | 316.31 |
| Amount Yet to be Received | 21.19 |
| Total Utilized | 428.81 |
Apollo Group Partnership
CARE Ratings Limited noted that over ₹200 crore from the received funds was transferred to Apollo group companies for dealer financing activities, where these companies act as anchors. This deployment aligns with the company's stated objective of meeting working capital needs as outlined in the offer document.
Regulatory Compliance and Monitoring
The monitoring agency report, prepared pursuant to Regulation 32(6) of SEBI LODR Regulations 2015, confirms complete compliance with regulatory requirements. CARE Ratings reported no material deviations from the objects stated in the offer document and no major deviations from previous monitoring agency reports.
| Compliance Parameter | Status |
|---|---|
| Utilization as per Offer Document | Yes |
| Material Deviations | Nil |
| Shareholder Approval Required | Not Applicable |
| Government Approvals | Not Applicable |
Issue Structure and Timeline
The preferential issue consists of warrants convertible into equity shares with an 18-month conversion period from the date of allotment. The funds are designated for working capital needs (₹440.00 crore) and general corporate purposes (₹10.00 crore). The completion timeline extends until April 30, 2027, with no delays reported so far.
Board Approval and Documentation
The monitoring agency report was reviewed and approved by the Audit Committee and Board of Directors in their meeting held on April 16, 2026. Company Secretary Kush Mishra submitted the report to BSE Limited and National Stock Exchange of India Limited, ensuring compliance with listing obligations. The report is also available on the company's website at www.sgfinserve.com .
Historical Stock Returns for SG Finserv
| 1 Day | 5 Days | 1 Month | 6 Months | 1 Year | 5 Years |
|---|---|---|---|---|---|
| -0.59% | +11.86% | +35.89% | +36.90% | +29.01% | +29.01% |
How will SG Finserve's expanded dealer financing operations through Apollo group partnerships impact its market share in the NBFC sector?
What are the potential risks and returns of SG Finserve's heavy concentration in dealer financing activities given the remaining ₹21.19 crore warrant conversion?
Will SG Finserve consider additional fundraising beyond the current warrant issue to further scale its operations before the April 2027 deadline?


































